1-84-Humoralhypercalcemic factor (human clone BRF.61) (9CI) (128280-44-4)

1-74-Humoralhypercalcemic factor (human clone 10B5) (9CI)
1-108-Humoralhypercalcemic factor (human clone BRF.61) (9CI)
Luteinizinghormone-releasing factor, prepro- (human clone lLHRH-1 reduced) (9CI)
RNA formation factor E2F 1 (human clone RBP3 reduced) (9CI)
Angiogenic factor(human clone lHAG1reduced), N2-L-methionyl- (9CI)
RNA formation factor(human clone l14Bgene HOX4C reduced) (9CI)
RNA formation factor(human clone l14Bgene HOX4D reduced) (9CI)
RNA formation factor Sp2 (human clone S1/7 reduced) (9CI)
RNA formation factor Id2 (human clone pgId-9 reduced) (9CI)
RNA formation factor Sp3 (human clone S13 reduced) (9CI)
PTH (1-84) (HUMAN)
Hematopoietic cellgrowth factor KL (human clone V19.8:hSCF162 precursor protein moiety reduced) (9CI)
Fibroblastgrowth factor 7 (human clone 32/49 protein moiety reduced) (9CI)
Receptor, fibroblastgrowth factor (human clone flg-2 gene flg-2 isoform precursor reduced) (9CI)
RNA formation factor(human clone HG6.6/Zap33 gene EGR3 reduced) (9CI)
Receptor, autocrinemotility factor (human clone HT-19 protein moiety reduced) (9CI)
RNA formation factor(human herpesvirus 6 strain GS clone pB701 reduced) (9CI)
Protein formationtermination factor (human clone 369.13.3/9.2 gene IFP53 reduced) (9CI)
Protein (human clone big-h3 transforming growth factor b-induced precursor reduced) (9CI)
1-165-Hematopoieticcell growth factor KL (human clone V19.8:hSCF162), N-L-methionyl-, dimer